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Summary 
Nitric oxide (NO) is believed to play an important role in sepsis-related hypotension. We e~amined 
the effects of two pore-forming bacterial exotoxins, Escherichia coil hemolysin and Staphylococcus 
aureus ol-toxin, on NO formation in cultured porcine pulmonary artery endothelial cells. NO 
was quantified using a difference-spectrophotometric  methodbased on the rapid and stoichiometric 
reaction of NO with oxyhemoglobin. Endothelial cyclic guanosine monophosphate levels were 
also monitored. Both exotoxins increased NO synthesis in endothelial cells in a time- and dose- 
dependent manner to an extent exceeding that observed with the ionophore A23187 or thrombin. 
The capacity of exotoxins to induce NO formation may be relevant in patients with severe local 
or systemic bacterial  infections. 
V 
ascular endothelial cells generate nitric oxide (NO) from 
the terminal guanido nitrogen of I.-arginine yielding t- 
citruUine as a coproduct (1). NO accounts for the biological 
actions of endothelium-derived relaxing factor, which plays 
a critical role in regulating vascular tone by stimulating the 
soluble guanylate cyclase in different target cells (2, 3). En- 
dothelial NO synthase is a NADPH-, Ca  2+-, and calmod- 
ulin-dependent enzyme that has been found in both cyto- 
solic and particulate cell fractions (3-6). 
It has been proposed that enhanced NO synthesis con- 
tributes to severe arterial hypotension, which is a hallmark 
of septic shock (7, 8). This concept evolved primarily from 
studies that employed t-arginine analogs as inhibitors of NO 
synthesis (7, 8). Another line of support derived from the 
demonstration of an immediate release of an NO-like factor 
from aortic endothelial cells by Escherichia coli LPS (9). How- 
ever, the latter data have not been confirmed (10). 
Whether or not proteinaceous bacterial cytotoxins may in- 
duce endothelial NO generation is unknown. Staphylococcal 
c~-toxin is a potentially relevant pathogenicity factor that is 
secreted by most strains of Staphylococcus aureus as a hydrophilic 
single chain polypeptide. After binding to a target lipid bilayer, 
toxin molecules oligomerize to form amphiphilic ring-shaped 
hexamers that become partially embedded within the lipid 
bilayer  to generate aqueous transmembrane pores (11, 12). 
In highly susceptible cells, the pores may act as nonselective 
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gates for Ca  2+ ions (11, 13, 14). An increase in intracelluhr 
free Ca  2+  has been linked to toxin-induced generation of 
prostacyclin  in endothelial cells (13) and of leukotriene B4 
in granulocytes (15). E. coli hemolysin (HlyA) is considered 
an important virulence factor and hemolysin production is 
strongly associated with extraintestinal E. coli infections (16). 
Endothelial cells, granulocytes, and renal epithelial cells are 
highly susceptible targets (17-24).  Generation of transmem- 
brahe pores is also the mechanism underlying the action of 
this widespread exotoxin (17, 18, 25).  Interest in HlyA is 
expanding rapidly since this agent is the major cytotoxin pro- 
duced by E. coli (26) and represents the prototype of a large 
family of toxins that are relevant in human and veterinary 
medicine (27-32). 
In the present study, we examined the ability of E.  coli 
HlyA and S. aureus ol-toxin to induce endothelial NO syn- 
thesis. We report that both toxins stimulate endothelial NO 
synthesis to degrees rivaling and even exceeding those pro- 
voked by the Ca  2+  ionophore A23187  or thrombin. The 
results identify a potentially important mechanism by which 
pore-forming toxins may induce hypotension in the course 
of severe infections or septic  shock. 
Materials and Methods 
Materials.  Tissue  culture plasticware  was obtained from Becton 
Dickinson (Heidelberg, Germany). Medium 199, FCS, HBSS, PBS, 
trypsin-EDTA solution, Hepes, and antibiotics were from Gibco 
(Karlsruhe, Germany). Collagenase (CLS type II) was purchased 
from Worthington Biochemical  Corp. (Freehold, NJ). Cytodex 3 
microcarrier  beads and Sephadex  G-25 column were obtained from 
Pharmacia (Uppsala, Sweden). Bovine hemoglobin, NG-nitro-t  - 
arginine (NNA),  t-arginine, A23187, and thrombin were from 
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Schuchardt (Munich,  Germany). NC-monomethyl-t-arginine ci- 
trate was obtained from Uhrafine Chemicals (Manchester,  UK). 
The  12SI-cGMP assay  system  was  from  Amersham  Buchler 
(Braunschweig,  Germany). LPS from Salmonella abortus equi was 
kindly provided by Dr. C. Galanos (Max-Planck-Institute,  Freiburg, 
Germany). 
Preparation of  E. coli HlyA and S. Aureus or-toxin.  LPS-depleted 
HlyA was prepared as described (19). The endotoxin content of 
the preparation was reduced to <3 ng of LPS/#g protein.  The 
hemolytic titer was assessed directly before use and expressed in 
hemolytic units (HU/ml) (17, 18); 1 HU/ml HlyA corresponded 
to '~100 ng protein/ml. Toxin activity was lost rapidly at 37~ 
("aged" toxin) (17, 18). This well-known property of the toxin 
was exploited to exclude possible effects of  contaminating LPS (19, 
33). S. aureus c~-toxin was purified as described by Bhakdi et al. (34). 
Preparation of Endothelial Cells.  Pulmonary artery endothelial 
cells were isolated from freshly slaughtered pigs by exposure to 0.1% 
collagenase  for 12-15 rain. Cells were characterized, maintained, 
and dispersed  as previously described (13,  33,  35).  All  studies 
(quantification of NO or cGMP, lactate dehydrogenase [LDH] re- 
lease, use ofinhibitors) were performed on endothelial cells in their 
third passage. 
Endothelial Cells on  Microcarrier Beads and  Experimental Pro- 
tocol.  Third-passage cells were grown in medium 199/10% FCS 
on Cytodex 3 microcarrier beads for 5-8 d until confluence (36). 
Cells on 5 ml packed beads were then washed several times and 
preincubated with  10 ml PBS containing 4 #M oxyhemoglobin 
for 30 rain. A  1-ml aliquot was taken, spun at 500 g  for 5 rain, 
and the supernatant used for NO determination (time 0, control). 
Stimuli (E. coli  HIyA, staphylococcal ol-toxin, A23187, or thrombin) 
were added,  and aliquots of the bead suspension  were taken at 
different time points for NO determinations. In some experiments, 
cells were preincubated with different concentrations of NNA for 
30 rain. 
Determination of NO.  Endothelial NO synthesis was quantified 
using a difference.spectrophotometric method based on the rapid 
and stoichiometric reaction of NO with oxyhemoglobin to yield 
methemoglobin and nitrate as described by Feelisch and Noack (37). 
For this,  the extinction difference between the absorption max- 
imum and the isobestic point of oxyhemoglobin versus methemo- 
globin (401 and 411 nm) was recorded using a spectrophotometer 
(Uvikon, Munich, FKG) (38). For preparation of oxyhemoglobin, 
bovine hemoglobin was dissolved in water,  equilibrated with ox- 
ygen, reduced with a molar excess of sodium dithionite, and purified 
on Sephadex G-25 columns (38). Methemoglobin was prepared by 
treating hemoglobin with a 10-fold molar excess of potassium fer- 
ricyanide, before gel titration (38). NO biosynthesis was also moni- 
tored by determining  endothelial  cGMP  levels. Confluent  cell 
monolayer  in  24-weli  plates  were  washed  and  stimulated  in 
HBSS/Hepes for 30 s-30 min in the presence  of the unselective 
phosphodiesterase inhibitor isobutyl-methylxanthine. Then cells 
were extracted twice with 0.5 ml ice-cold 65% ethanol. Extracts 
were evaporated under a stream of nitrogen at 60~  and dissolved 
in assay buffer. Aliquots of the extracts and of the standards  were 
acetylated by addition of acetic anhydride and triethylamine (1:2) 
to enhance the sensitivity of cGMP detection 09). 
Determination of  LDH.  LDH release from cell monolayers cul- 
tured in 24-well plates was used as a marker of overt cytotoxicity. 
The medium was removed and centrifuged at 8,000 g for 2 min. 
LDH activity in the supernatant was determined by the colori- 
metric measurement of the reduction of sodium pyruvate in the 
presence of NADH as described (40). Enzyme release was expressed 
as the percentage of total enzyme activity liberated from endothelial 
cells in the presence of 100/~g/ml mdlitin (35,  40). 
Statistical Methods.  Depending on the number of groups (A) 
and the number of different time points studied (B), data of Figs. 
1 and 3 were analyzed by an A  x  B analysis of  variance (ANOVA). 
A one-way ANOVA was used for data of Fig. 2. p <0.05 was con- 
sidered  significant  (41). 
Results  and  Discussion 
Unstimulated endothdial cells produced NO at a rate of 
12  +  3.9 praoles/min/ral packed beads. This rate of sponta- 
neous NO synthesis was coraparable to that reported by Kelm 
et al.  (38).  E.  coli HlyA dose (0.05-1.0 HU/ral)  and time 
dependently increased NO generation in porcine pulmonary 
artery endothdial cells (Fig. 1 A). After 30 rain, 1.83 _+ 0.145 
nraoles NO/ral  packed beads were generated (3.2  _  0.22 
nmoles NO after 60 rain) through the action of 1 HU/ml 
HlyA. Staphylococcal or-toxin also induced endothelial NO 
synthesis in a dose- and time-dependent manner. 1.31 _+ 0.065 
nmoles NO/ral  packed beads were generated after 30 rain 
in the presence of 1/~g/ral  staphylococcal oe-toxin (Fig.  1 
B).  In this system, staphylococcal o~-toxin and HIyA were 
thus as potent as 10 #M A23187 (Fig.  1 C). Throrabin (2 
U/ral)  increased NO  synthesis to raaxiraally  0.72  __.  0.06 
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Figure  1.  StimulationofNOgenerationinpulmonaryendothelialcdls 
by E. coli HIyA, '3. aureus c~-toxin, the ionophore A23187, and thrombin. 
NO was quantified by monitoring  the oxidation of hemoglobin (see 
Materials and  Methods).  0.05 HU/ml  HlyA  (A)  and  0.05 /~g/ml 
staphylococcal  c~-toxin  (B) or more significantly  increased  endothelial  NO 
synthesis. The effects of 10 #M A23187 (C) and 1 U/ml thrombin (/9) 
were also significant above baseline NO formation. Data presented are 
mean ~  SE of six (tt and B) and four (C and D) separate experiments. 
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teau after 15 rain (Fig. 1 D). From Fig. 1, the following rank 
order of NO-inducing potency emerged: E.  coli HIyA > $. 
aureus  cz-toxin  =  A23187 >  thrombin. Incubation of en- 
dothdial cells with 100 ng/ml LPS for 1 h did not increase 
NO synthesis (data not shown). "Aged" HlyA (toxin kept 
at 37~  for 6 h) also did not stimulate  NO formation. 
NNA was used as an arginine analog to confirm that he- 
moglobin oxidation was NO related. 2.5 and 10 #M NNA 
reduced A23187-induced  NO  synthesis  by 75  and 95%, 
respectively. 
cGMP content in endothelial cells was determined as an 
indirect parameter of NO synthesis (Fig. 2). Both toxins in- 
duced a rapid increase in endothelial cGMP levels. HlyA at 
the very low concentrations of 0.05-0.1  HU/ml was again 
observed to be as potent as the Ca  2+ ionophore A23187, in- 
ducing a 10-fold increase in cGMP concentrations within 5 
min. S. aureus or-toxin at 0.5 #g/ml also induced a marked, 
approximately fivefold increase in cGMP. Thrombin again 
was the weakest stimulus, inducing only an approximately 
twofold cGMP increase. NNA abrogated the observed effects 
in all cases (Fig. 2).  It is of interest  that cGMP levels did 
not increase in the presence of hemoglobin, suggesting that 
endothelial ceU-derived NO acted in a paracrine (not auto- 
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Figure  2.  cGMP content of pulmonary artery endothelial cells was used 
as an indirect  parameter  of endothelial  NO synthesis, cGMP-levels were 
increased significantly  by >0.05 HU/ml HlyA, >0.5/zg/ml or-toxin,  1 
#M A23187, or 2 U/ml thrombin. In the presence of 10 ~M NNA or 
hemoglobin endothelial cGMP concentrations were reduced to basic levels. 
Data are given as pmol cGMP/106 endothelial  cells 5 min after stimula- 
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Figure  3.  Effect of Ca  z+ depletion on stimulation of NO synthesis in 
pulmonary endothelial cells by staphylococcal cr  and the ionophore 
A23187. In the absence of extracellular Ca  2+ (filled symbols) staphylococcal 
cr  (0.5/~g/ml)-induced NO synthesis was abrogated.  Under these 
conditions  A23187-related NO formation was also strongly reduced and 
only slightly  above baseline at 30 rain (B). Data presented  are mean  _+ 
SE of four separate experiments. 
To further characterize exotoxin-related stimulation of NO 
synthesis in endothelial cells, experiments were performed 
in the absence of extracellular Ca  2  §  The effect of staphylo- 
coccal ol-toxin on endothelial NO formation was abrogated 
under these conditions, suggesting that an influx of extracel- 
lular Ca  2+ is important for the action of this toxin (Fig. 3 
A). A23187-related NO synthesis was also strongly reduced 
and only slightly  above baseline at 30 min (Fig. 3 B). 
LDH release was not enhanced in A23187- and thrombin- 
stimulated cells. Slight cytolysis occurred in endothelial cells 
after  stimulation  with  maximal  HlyA or  staphylococcal 
c~-toxin concentrations  at 30-60 min. 1 HU/ml HlyA in- 
creased LDH release to 12.3 _+  1.7% in 30 rain, and 1 #g/ml 
staphylococcal c~-toxin to 13.2 _+ 4.3% in 60 min over their 
baseline controls.  Thus, stimulation of NO formation oc- 
curred at toxin concentrations well below those required to 
cause overt cytolysis. 
Salvemini et al. (9) reported on an immediate release of 
a NO-like factor from bovine aortic endothelial cells induced 
by high (10 #g/ml) concentrations of E. coli LPS. Although 
this was later contested by Myers et al. (10), the possibility 
remained that NO synthesis observed in our experiments may 
have been due to contaminating endotoxin. However, our 
HIyA preparations contained <3 ng LPS/#g protein so that 
LPS concentrations were well below 2-5 ng/ml at the highest 
HlyA concentrations employed. Incubation of cells with up 
to 100 ng/ml endotoxin did not increase endothelial NO syn- 
thesis within 1 h. Furthermore, "aged" HlyA which had lost 
its cytotoxic activity also no longer provoked NO release. 
These data therefore virtually exclude a direct effect of con- 
taminating LPS in our experiments. They do not exclude a 
possible synergistic interaction between HlyA and low LPS 
concentrations. That a pore-forming proteinaceous toxin alone 
is capable of inducing NO release from endothelial cells was 
apparent from the results obtained with S.  aureus ol-toxin, 
which was derived from a gram-positive (LPS-free)  organism. 
Further experiments are required to delineate the mecha- 
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in endothelial cells. Ca  2+ influx is an obvious candidate and 
the initial experiments reported here for staphylococcal c~-toxin 
are in accord with this basic idea.  Experiments with HlyA 
are underway, but they are impeded by the fact that HIyA 
preparations contain high concentrations of Ca  2  + and that 
HIyA requires  Ca  2+  in order to bind to cells (42,  43). 
These unresolved questions notwithstanding, the present 
study shows that proteinaceous exotoxins released in the vi- 
cinity of vascular endothelium may potently and rapidly pro- 
voke NO release, thus providing a novel pathway leading to 
hypotension and organ failure. 
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